As Senior Vice President of Strategic Initiatives at the New York Stem Cell Foundation, Stephen Chang is one of the leading experts in gene therapy and neurodegenerative. Dr. Chang speaks with Brett Johnson on the state of the industry, explains what we can expect from the field in the future and offers his advice for investors and entrepreneurs who are active in the space. Brett Johnson: Can you give an update as to what’s happened since we spoke last at the New York Stem Cell Foundation? Any developments? Stephen Chang: It is exciting times. We are moving into a new…
Browsing: INTERVIEWS (Under Construction)
Thought leaders engaged in pursuing cures for infectious disease.
OmniCyte Founder, Peter Leonardi, provides insight into the emerging field of immunotherapy. Immunotherapy is the process that uses the body’s natural defense system to cure cancer. The most popular area is in checkpoint inhibitors, which remove the blockade that defends the cancer cells from the body’s natural defenses. Brett Johnson interviews Dr. Leonardi to discuss OmniCyte’s emerging technique that involves the enhancement of the body’s ability to attack cancer. Brett Johnson: Cancer immunotherapy has become a very exciting area both in general and for investors. What is cancer immunotherapy? Peter Leonardi: Cancer immunotherapy, or immune-oncology, is the use of the body’s…